TSPAN32 and hematopoietic and lymphoid cell neoplasm: Earlier studies have demonstrated that TSPAN32 plays a critical role in maintaining immune homeostasis, and its dysregulation has been associated with altered immune responses and susceptibility to autoimmune diseases and haematopoietic cancer [21, 22, 23, 32, 35, 36].